About VISIE
VISIE is a company based in Austin (United States) founded in 2017 by Aaron Bernstein and Patrick Edwards.. VISIE has raised $12.71 million across 9 funding rounds from investors including Epilepsy Foundation, Capital Factory and Medingenii. VISIE offers products and services including 3D Spatial Computing Platform and 3D Scanners. VISIE operates in a competitive market with competitors including Caresyntax, Haemonetics, ClearPoint Neuro, Cydar Medical and Inscopix, among others.
- Headquarter Austin, United States
- Founders Aaron Bernstein, Patrick Edwards
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Visie Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$12.71 M (USD)
in 9 rounds
-
Latest Funding Round
$2.97 M (USD), Series A
Apr 30, 2025
-
Investors
Epilepsy Foundation
& 8 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of VISIE
VISIE offers a comprehensive portfolio of products and services, including 3D Spatial Computing Platform and 3D Scanners. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for 3D vision to enhance surgical accuracy and navigation.
Investigational tools for precise anatomical tracking in surgery.
Funding Insights of VISIE
VISIE has successfully raised a total of $12.71M across 9 strategic funding rounds. The most recent funding activity was a Series A round of $2.97 million completed in April 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 9
- Last Round Series A — $3.0M
-
First Round
First Round
(01 Jan 2018)
- Investors Count 9
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2025 | Amount | Series A - VISIE | Valuation |
investors |
|
| Nov, 2023 | Amount | Series A - VISIE | Valuation |
investors |
|
| Feb, 2021 | Amount | Series A - VISIE | Valuation | Capital Factory |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in VISIE
VISIE has secured backing from 9 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include Epilepsy Foundation, Capital Factory and Medingenii. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Acceleration is provided to seed-stage, early-stage, and later-stage companies.
|
Founded Year | Domain | Location | |
|
Medingenii is engaged in investing in healthcare innovation companies.
|
Founded Year | Domain | Location | |
|
Cartmell Ventures is focused on early-stage health IT investments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by VISIE
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - VISIE
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Visie Comparisons
Competitors of VISIE
VISIE operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Caresyntax, Haemonetics, ClearPoint Neuro, Cydar Medical and Inscopix, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Surgical outcomes are enhanced via analytics and integration platform.
|
|
| domain | founded_year | HQ Location |
Hematology products and solutions are provided for medical applications.
|
|
| domain | founded_year | HQ Location |
Software and hardware solutions for MRI-guided surgical planning are provided.
|
|
| domain | founded_year | HQ Location |
Surgical images are analyzed via AI for endovascular procedures.
|
|
| domain | founded_year | HQ Location |
Miniscope platforms are developed for decoding brain neural circuits.
|
|
| domain | founded_year | HQ Location |
Solutions for image-guided interventional procedures are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Visie
Frequently Asked Questions about VISIE
When was VISIE founded?
VISIE was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Where is VISIE located?
VISIE is headquartered in Austin, United States. It is registered at Austin, Texas, United States.
Who is the current CEO of VISIE?
Douglas Fairbanks Fairbanks is the current CEO of VISIE.
Is VISIE a funded company?
VISIE is a funded company, having raised a total of $12.71M across 9 funding rounds to date.
What does VISIE do?
Provider of 3D intraoperative imaging technology for orthopedic, neuro, and spine surgery. The companys proprietary maging hardware combines the power of science and deep tech to develop intraoperative scanners to streamline surgeries in the operating room.
Who are the top competitors of VISIE?
VISIE's top competitors include Caresyntax, ClearPoint Neuro and Haemonetics.
What products or services does VISIE offer?
VISIE offers 3D Spatial Computing Platform and 3D Scanners.
Who are VISIE's investors?
VISIE has 9 investors. Key investors include Epilepsy Foundation, Capital Factory, Medingenii, Cartmell Ventures, and Flat Rock Global.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.